UNT researchers credited with cancer breakthrough

A research team including UNT biology professor Ron Mittler and adjunct professor Rachel Nechushtai made a major discovery that could help fight many deadly forms of cancer. The team determined a way to suppress a protein found frequently in five lethal cancers, therefore halting tumor growth. They discovered that Pioglitazone, a drug approved for the treatment of diabetes, can mimic a lab mutation that stalls future development of tumors. Clinical trials are the next step in the research. The team also hopes this new knowledge will be used to design a drug that exclusively fights cancers involving this protein, with few side effects.

No comments available.

Add your comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img><b><i> <div> <br> <p> <h1> < h2> <h3> <h4>
  • Lines and paragraphs break automatically.

More information about formatting options

By submitting this form, you accept the Mollom privacy policy.